CHRISTOPHER RICHARD
SEC insider (Form 3/4/5 filer). CIK 0001271244. Chief Executive Officer at Lexaria Bioscience Corp. (LEXX). 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 29, 2025. Located in ROCHESTER, NY.
Companies CHRISTOPHER RICHARD has filed insider reports for
- Lexaria Bioscience Corp. (LEXX): Officer, Chief Executive Officer
CHRISTOPHER RICHARD
CIK: 0001271244
Transaction Breakdown
Open Market Buys (P)3 (75.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LEXX
Lexaria Bioscience Corp.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 29, 2025LEXX
Lexaria Bioscience Corp.
PurchaseDirect15K shares at avg. $0.91$14K - May 15, 2025LEXX
Lexaria Bioscience Corp.
AwardDirectStock Options
150K shares- - Dec 3, 2024LEXX
Lexaria Bioscience Corp.
PurchaseDirect27.2K shares at avg. $2.47$67K - Dec 2, 2024LEXX
Lexaria Bioscience Corp.
PurchaseDirect22.8K shares at avg. $2.24$51K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 29, 2025 | LEXX Lexaria Bioscience Corp. | Purchase | 15,000 | $0.91 | $13,641 | Direct |
| May 15, 2025 | LEXX Lexaria Bioscience Corp. | Award Stock Options | 150,000 | - | - | Direct |
| Dec 3, 2024 | LEXX Lexaria Bioscience Corp. | Purchase | 27,172 | $2.47 | $67,175 | Direct |
| Dec 2, 2024 | LEXX Lexaria Bioscience Corp. | Purchase | 22,828 | $2.24 | $51,217 | Direct |
1-4 of 4 transactions